FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070862506> ?p ?o ?g. }

• W2070862506 endingPage "59" @default.
• W2070862506 startingPage "47" @default.
• W2070862506 abstract "Meta-analyses of oral hypoglycemic agents (OHAs) revealed that rosiglitazone increased the risk of myocardial infarction (MI) and heart failure (HF) and that pioglitazone increased the risk of HF and decreased the risk of MI. To characterize the change in the pattern of use of OHAs immediately after the publication of these meta-analyses on May 21, 2007. Pharmacy and medical claims data for a managed care organization were analyzed for patients continuously enrolled from January 1, 2005, to November 30, 2007, with at least 1 pharmacy claim for OHA in the 13-month period between November 1, 2006, and November 30, 2007. A 5-month pre-publication period (November 1, 2006, through March 31, 2007) was compared with a 5-month post-publication period (July 1, 2007, through November 30, 2007) using a differences-in-differences multinomial logistic regression. This regression explored discontinuation; continuation with monotherapy or adding another drug; and switching to a drug different from the index monotherapy drug after adjusting for gender, age, type of insurance, past 1-year history of MI or HF, and risk factors for MI and HF in the past 1 year. The relative rate of switching to nonindex drug in the postpublication relative to prepublication was 2.64 (P = .046) for monotherapy rosiglitazone users and 0.72 (P = .583) for monotherapy pioglitazone users. The differences-in-differences estimate of the rate of switching to nonindex drugs for monotherapy rosiglitazone users was 3.64 (P = .090) times higher relative to the estimate for monotherapy pioglitazone users. The pattern of use differed fundamentally between monotherapy rosiglitazone users and users of all other monotherapy OHAs in the postperiod. Not only were monotherapy rosiglitazone patients switching to non-rosiglitazone drugs at a higher rate, but the rate also was more than 3 times higher than similar switches among monotherapy pioglitazone users in the postperiod relative to the preperiod. This shows that the market response as observed by patient/prescriber decisions to the adverse news was interpreted narrowly to monotherapy rosiglitazone, and there is little or no spillover to the other drugs. Therefore, this study found that there was a differential effect of meta-analyses on the use of the 2 drugs." @default.
• W2070862506 created "2016-06-24" @default.
• W2070862506 creator A5027695585 @default.
• W2070862506 creator A5062646947 @default.
• W2070862506 creator A5063272024 @default.
• W2070862506 creator A5070395450 @default.
• W2070862506 date "2012-01-01" @default.
• W2070862506 modified "2023-09-30" @default.
• W2070862506 title "Use of rosiglitazone and pioglitazone immediately after the cardiovascular risk warnings" @default.
• W2070862506 cites W1504344187 @default.
• W2070862506 cites W1584886768 @default.
• W2070862506 cites W1972504730 @default.
• W2070862506 cites W1987941106 @default.
• W2070862506 cites W1990724339 @default.
• W2070862506 cites W2014698146 @default.
• W2070862506 cites W2016513014 @default.
• W2070862506 cites W2016767411 @default.
• W2070862506 cites W2049097098 @default.
• W2070862506 cites W2049350168 @default.
• W2070862506 cites W2055160702 @default.
• W2070862506 cites W2080836692 @default.
• W2070862506 cites W2085095809 @default.
• W2070862506 cites W2088696557 @default.
• W2070862506 cites W2127125241 @default.
• W2070862506 cites W2158376518 @default.
• W2070862506 cites W2159969745 @default.
• W2070862506 cites W2164160382 @default.
• W2070862506 cites W2164367541 @default.
• W2070862506 cites W2764148593 @default.
• W2070862506 cites W4244681915 @default.
• W2070862506 cites W4247732714 @default.
• W2070862506 doi "https://doi.org/10.1016/j.sapharm.2010.12.003" @default.
• W2070862506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21733760" @default.
• W2070862506 hasPublicationYear "2012" @default.
• W2070862506 type Work @default.
• W2070862506 sameAs 2070862506 @default.
• W2070862506 citedByCount "12" @default.
• W2070862506 countsByYear W20708625062012 @default.
• W2070862506 countsByYear W20708625062013 @default.
• W2070862506 countsByYear W20708625062015 @default.
• W2070862506 countsByYear W20708625062016 @default.
• W2070862506 countsByYear W20708625062017 @default.
• W2070862506 countsByYear W20708625062018 @default.
• W2070862506 countsByYear W20708625062019 @default.
• W2070862506 crossrefType "journal-article" @default.
• W2070862506 hasAuthorship W2070862506A5027695585 @default.
• W2070862506 hasAuthorship W2070862506A5062646947 @default.
• W2070862506 hasAuthorship W2070862506A5063272024 @default.
• W2070862506 hasAuthorship W2070862506A5070395450 @default.
• W2070862506 hasConcept C104863432 @default.
• W2070862506 hasConcept C126322002 @default.
• W2070862506 hasConcept C134018914 @default.
• W2070862506 hasConcept C151956035 @default.
• W2070862506 hasConcept C170493617 @default.
• W2070862506 hasConcept C2777180221 @default.
• W2070862506 hasConcept C2778384471 @default.
• W2070862506 hasConcept C2778715236 @default.
• W2070862506 hasConcept C2780152017 @default.
• W2070862506 hasConcept C44249647 @default.
• W2070862506 hasConcept C500558357 @default.
• W2070862506 hasConcept C512399662 @default.
• W2070862506 hasConcept C555293320 @default.
• W2070862506 hasConcept C71924100 @default.
• W2070862506 hasConcept C82789193 @default.
• W2070862506 hasConceptScore W2070862506C104863432 @default.
• W2070862506 hasConceptScore W2070862506C126322002 @default.
• W2070862506 hasConceptScore W2070862506C134018914 @default.
• W2070862506 hasConceptScore W2070862506C151956035 @default.
• W2070862506 hasConceptScore W2070862506C170493617 @default.
• W2070862506 hasConceptScore W2070862506C2777180221 @default.
• W2070862506 hasConceptScore W2070862506C2778384471 @default.
• W2070862506 hasConceptScore W2070862506C2778715236 @default.
• W2070862506 hasConceptScore W2070862506C2780152017 @default.
• W2070862506 hasConceptScore W2070862506C44249647 @default.
• W2070862506 hasConceptScore W2070862506C500558357 @default.
• W2070862506 hasConceptScore W2070862506C512399662 @default.
• W2070862506 hasConceptScore W2070862506C555293320 @default.
• W2070862506 hasConceptScore W2070862506C71924100 @default.
• W2070862506 hasConceptScore W2070862506C82789193 @default.
• W2070862506 hasIssue "1" @default.
• W2070862506 hasLocation W20708625061 @default.
• W2070862506 hasLocation W20708625062 @default.
• W2070862506 hasOpenAccess W2070862506 @default.
• W2070862506 hasPrimaryLocation W20708625061 @default.
• W2070862506 hasRelatedWork W1956824960 @default.
• W2070862506 hasRelatedWork W1996968608 @default.
• W2070862506 hasRelatedWork W2016647823 @default.
• W2070862506 hasRelatedWork W2065150946 @default.
• W2070862506 hasRelatedWork W2068370293 @default.
• W2070862506 hasRelatedWork W2115946307 @default.
• W2070862506 hasRelatedWork W2126218135 @default.
• W2070862506 hasRelatedWork W2126639993 @default.
• W2070862506 hasRelatedWork W2163886829 @default.
• W2070862506 hasRelatedWork W2802058755 @default.
• W2070862506 hasVolume "8" @default.
• W2070862506 isParatext "false" @default.
• W2070862506 isRetracted "false" @default.
• W2070862506 magId "2070862506" @default.

• next